| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | AGR3; BCMP11; Anterior gradient protein 3 homolog; AG-3; AG3; hAG-3; Breast cancer membrane protein 11 |
| Clonality | |
| Concentration | |
| Formulation | |
| Gene ID | |
| Host | |
| Immunogen | The antiserum was produced against synthesized peptide derived from human AGR3. AA range:1-50 |
| Isotype | |
| Molecular Weight | |
| Product Type | |
| Reactivity | |
| Storage | |
| Target |
Product Overview
Primary AntibodyThis antibody targets AGR3 and detects endogenous levels of AGR3 protein.
Validated Applications
| Application | Dilution Guidance |
|---|---|
| Immunohistochemistry (IHC) | Refer to datasheet for recommended working dilution |
| Immunofluorescence (IF) | Refer to datasheet for recommended working dilution |
| ELISA | Refer to datasheet for recommended working dilution |
Antibody Specifications
| Target | AGR3 |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Reactivity | Human, Mouse |
| Purification | Affinity Purification |
| Molecular Weight | ~19.2 kDa |
| Concentration | 1 mg/ml |
| Immunogen | The antiserum was produced against synthesized peptide derived from human AGR3. AA range:1-50 |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Storage | -20°C for 1 year |
| Gene ID | Human: 155465; Mouse: 403205 |
| UniProt | Q8TD06 (Human: Q8TD06; Mouse: Q8R3W7) |
Scientific Background
AGR3 (Anterior Gradient 3, Protein Disulphide Isomerase Family Member) is a Protein Coding gene. Diseases associated with AGR3 include breast abscess and ritter's disease. GO annotations related to this gene include dystroglycan binding. An important paralog of this gene is TXNDC12. equired for calcium-mediated regulation of ciliary beat frequency and mucociliary clearance in the airway. Might be involved in the regulation of intracellular calcium in tracheal epithelial cells.
Alternative Names
AGR3; BCMP11; Anterior gradient protein 3 homolog; AG-3; AG3; hAG-3; Breast cancer membrane protein 11
Safety & Handling
| Target | AGR3 |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Reactivity | Human, Mouse |
| Purification | Affinity Purification |
| Molecular Weight | ~19.2 kDa |
| Concentration | 1 mg/ml |
| Immunogen | The antiserum was produced against synthesized peptide derived from human AGR3. AA range:1-50 |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Storage | -20°C for 1 year |
| Gene ID | Human: 155465; Mouse: 403205 |
| UniProt | Q8TD06 (Human: Q8TD06; Mouse: Q8R3W7) |
Optimized working dilutions depend on sample type and detection system. Titration is recommended.
| Application | Dilution Note |
|---|---|
| Immunohistochemistry (IHC) | Refer to datasheet for recommended working dilution |
| Immunofluorescence (IF) | Refer to datasheet for recommended working dilution |
| ELISA | Refer to datasheet for recommended working dilution |
AGR3 (Anterior Gradient 3, Protein Disulphide Isomerase Family Member) is a Protein Coding gene. Diseases associated with AGR3 include breast abscess and ritter's disease. GO annotations related to this gene include dystroglycan binding. An important paralog of this gene is TXNDC12. equired for calcium-mediated regulation of ciliary beat frequency and mucociliary clearance in the airway. Might be involved in the regulation of intracellular calcium in tracheal epithelial cells.
Alternative Names
AGR3; BCMP11; Anterior gradient protein 3 homolog; AG-3; AG3; hAG-3; Breast cancer membrane protein 11
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
